Statistics

Total Visits

Views
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer95

Select a period of time:

Number of views in the range

Views
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer31

Views

Views
November 20259
December 20256
January 20262
February 20260
March 20261
April 20267
May 20266
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
Brazil3
Canada2
Germany2
Egypt2
United Kingdom2
Argentina2
France1
Libya1
 

Top cities views

Views
San Jose4
Frankfurt am Main2
Ajax1
Ashburn1
Brockville1
Cairo1
Danville1
Giza1
Icaraíma1
Lille1